RxDoctor Payments Data

Devin Tetter

Nurse Practitioner · Asheboro, NCNPI 1598478547

Payments from drug & device makers

$2,604in general payments, 2019–2025

Across 141 payments — averaging $18.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$523
  • Lilly USA, LLC$437
  • Novo Nordisk$266
  • Bayer$232
  • AbbVie$188
  • GSK$122
  • plus $837 from 14 others

What the payments were for

  • Food & beverage$2,52497%
  • Education$803%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,604 in reported general payments places this provider in the 85th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide47$57,523
FarxigaDapagliflozin Propanediol45$53,672
Trelegy ElliptaFluticasone/Umeclidin/Vilanter54$38,778
JardianceEmpagliflozin24$28,409
MounjaroTirzepatide13$17,614
XareltoRivaroxaban11$16,172
LinzessLinaclotide12$15,781
Tresiba Flextouch U-100Insulin Degludec18$10,856
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$10,774
JanuviaSitagliptin Phosphate12$10,294
Gabapentin145$2,546
Albuterol Sulfate HfaAlbuterol Sulfate102$2,103
Hydroxyzine Hcl32$1,282
Omeprazole76$973
Ventolin HfaAlbuterol Sulfate16$895

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$523$64,44558 claims
Novo NordiskOzempic$266$57,52347 claims
GSKTrelegy Ellipta$122$38,77854 claims
Boehringer IngelheimJardiance$59$28,40924 claims
Lilly USA, LLCMounjaro$437$17,61413 claims
Johnson & JohnsonXarelto$46$16,17211 claims
AbbVieLinzess$188$15,78112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,393 nurse practitioner providers in North Carolina.

Other nurse practitioner in Asheboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →